| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
52,815 |
51,463 |
$9.18M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,972 |
18,675 |
$6.38M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,594 |
9,456 |
$1.65M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,699 |
5,009 |
$498K |
| 80053 |
Comprehensive metabolic panel |
15,660 |
12,678 |
$456K |
| 87400 |
|
16,315 |
15,895 |
$275K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16,148 |
15,784 |
$265K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,638 |
1,576 |
$229K |
| 71046 |
Radiologic examination, chest; 2 views |
6,902 |
6,679 |
$188K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,384 |
2,097 |
$166K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,511 |
10,364 |
$155K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,509 |
4,411 |
$150K |
| 85027 |
|
24,759 |
20,229 |
$142K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,318 |
3,406 |
$135K |
| 87070 |
|
8,528 |
8,309 |
$133K |
| 86171 |
|
5,227 |
5,150 |
$117K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,856 |
4,712 |
$99K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,821 |
4,884 |
$83K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,094 |
5,845 |
$79K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
281 |
251 |
$73K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,186 |
1,083 |
$70K |
| 86833 |
|
619 |
521 |
$67K |
| G0378 |
Hospital observation service, per hour |
185 |
170 |
$65K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,476 |
1,368 |
$60K |
| 74018 |
|
1,979 |
1,927 |
$57K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
306 |
249 |
$49K |
| 71045 |
Radiologic examination, chest; single view |
4,985 |
4,349 |
$48K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
450 |
436 |
$32K |
| 81003 |
|
6,824 |
6,351 |
$29K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,937 |
1,584 |
$28K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
604 |
577 |
$28K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
800 |
619 |
$25K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
450 |
436 |
$24K |
| 84703 |
|
3,812 |
3,480 |
$23K |
| 81001 |
|
7,719 |
6,722 |
$22K |
| 86850 |
|
1,015 |
846 |
$19K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
366 |
333 |
$18K |
| 87040 |
|
1,466 |
1,286 |
$17K |
| 86140 |
|
1,725 |
1,664 |
$16K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,385 |
743 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
748 |
686 |
$15K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
491 |
196 |
$14K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,782 |
1,699 |
$14K |
| 84702 |
|
1,085 |
925 |
$13K |
| 84484 |
|
3,367 |
2,521 |
$13K |
| 81025 |
|
1,371 |
1,280 |
$12K |
| 76801 |
|
141 |
133 |
$12K |
| 80047 |
|
415 |
364 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
187 |
153 |
$11K |
| 76830 |
Ultrasound, transvaginal |
191 |
173 |
$10K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,514 |
1,677 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
169 |
151 |
$10K |
| 86832 |
|
161 |
136 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
237 |
216 |
$9K |
| 87799 |
|
1,057 |
785 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
133 |
106 |
$7K |
| 80197 |
|
2,577 |
1,384 |
$7K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
104 |
98 |
$7K |
| 83735 |
|
4,083 |
2,593 |
$7K |
| 83880 |
|
1,426 |
1,175 |
$6K |
| 83690 |
|
2,848 |
2,503 |
$6K |
| 87077 |
|
412 |
357 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
4,256 |
2,629 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$5K |
| 86900 |
|
2,213 |
1,843 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
136 |
94 |
$5K |
| 85610 |
|
2,412 |
2,066 |
$4K |
| 86901 |
|
2,212 |
1,842 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
805 |
681 |
$4K |
| 85730 |
|
2,076 |
1,789 |
$4K |
| 80061 |
Lipid panel |
816 |
672 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
64 |
52 |
$3K |
| 83605 |
|
813 |
692 |
$3K |
| 84100 |
|
3,165 |
1,973 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
109 |
99 |
$3K |
| 74019 |
|
110 |
109 |
$3K |
| 11043 |
|
26 |
13 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
795 |
642 |
$2K |
| 82570 |
|
2,294 |
1,322 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
120 |
111 |
$2K |
| 73560 |
|
42 |
40 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,415 |
3,639 |
$2K |
| 80320 |
|
444 |
417 |
$2K |
| 87186 |
|
436 |
377 |
$2K |
| 87275 |
|
56 |
56 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,005 |
1,412 |
$2K |
| 59025 |
Fetal non-stress test |
126 |
94 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
739 |
628 |
$2K |
| 87797 |
|
80 |
80 |
$2K |
| 84156 |
|
2,170 |
1,306 |
$2K |
| 87497 |
|
129 |
102 |
$1K |
| J3490 |
Unclassified drugs |
570 |
438 |
$1K |
| 80143 |
|
400 |
368 |
$1K |
| 87205 |
|
285 |
227 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
224 |
179 |
$1K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
14 |
14 |
$1K |
| 96376 |
|
106 |
81 |
$960.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
40 |
38 |
$892.36 |
| 80179 |
|
442 |
408 |
$864.66 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
364 |
189 |
$857.69 |
| 88342 |
|
26 |
24 |
$823.05 |
| 83970 |
|
155 |
118 |
$779.77 |
| 94644 |
|
25 |
24 |
$741.47 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
469 |
365 |
$481.50 |
| 73610 |
|
13 |
13 |
$472.99 |
| 73130 |
|
14 |
14 |
$468.44 |
| 73090 |
|
28 |
25 |
$468.08 |
| J1644 |
Injection, heparin sodium, per 1000 units |
231 |
147 |
$467.94 |
| 72131 |
|
12 |
12 |
$447.63 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
50 |
41 |
$444.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,153 |
891 |
$440.97 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
54 |
54 |
$416.10 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
40 |
38 |
$413.91 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
862 |
435 |
$328.60 |
| 77080 |
|
28 |
26 |
$326.40 |
| 84443 |
Thyroid stimulating hormone (TSH) |
70 |
64 |
$305.10 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,820 |
2,215 |
$294.85 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
556 |
426 |
$275.81 |
| J7999 |
Compounded drug, not otherwise classified |
13 |
13 |
$143.58 |
| 80076 |
|
202 |
172 |
$139.85 |
| 87276 |
|
56 |
56 |
$135.00 |
| 86645 |
|
69 |
53 |
$98.55 |
| 86644 |
|
69 |
53 |
$84.18 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
95 |
86 |
$82.78 |
| 82565 |
|
12 |
12 |
$53.64 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
63 |
52 |
$39.53 |
| J7050 |
Infusion, normal saline solution, 250 cc |
235 |
189 |
$31.36 |
| 86803 |
|
33 |
24 |
$27.83 |
| 85378 |
|
14 |
12 |
$25.13 |
| 87340 |
|
16 |
12 |
$20.15 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
106 |
92 |
$5.43 |
| A9270 |
Non-covered item or service |
1,883 |
889 |
$3.60 |
| J2704 |
Injection, propofol, 10 mg |
213 |
184 |
$0.00 |
| C1769 |
Guide wire |
152 |
125 |
$0.00 |
| 82803 |
|
15 |
13 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
17 |
12 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
174 |
162 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
79 |
69 |
$0.00 |
| 93356 |
|
12 |
12 |
$0.00 |